Murtech, Inc.

Murtech, Inc., a veteran-owned small business based in Glen Burnie, Maryland, operates as a prime contractor (99% of recent awards) providing specialized logistics, manufacturing, storage, and distribution services for Department of Defense chemical and biological defense programs, with secondary work in military watercraft sustainment and unmanned surface vehicle integration. The company competes full-and-open, not under set-aside vehicles, though several of its single-award indefinite delivery contracts were solicited as small business set-asides.

Murtech's customer concentration is extreme: the Joint PEO Chemical and Biological Defense accounts for 55 awards valued at $10.43 billion in combined potential value (76% of the total portfolio), with the Department of the Army Procurement Project Management Office for Professional, Business, and Use-Engineered Services contributing an additional 16 awards at $1.53 billion. The top five customer organizations account for 91% of awards by count and 100% of combined potential value. This concentration reflects Murtech's deep specialization in chemical and biological defense logistics and manufacturing rather than diversified defense contracting.

Murtech holds six active indefinite delivery contracts anchoring its federal work. The Joint Enterprise Contracted Logistics and Services Support Class II (JE-CLASS II) carries a $906.57 million ceiling and has generated at least 14 task orders worth $28.3 million in combined potential value since January 2023, covering performance-based logistics and contractor logistics support for fielded chemical and biological detection equipment globally. A $35 million single-award IDC (September 2023–September 2028) is dedicated to manufacturing lateral flow immunoassay strips for the Defense Biological Product Assurance Office, with three delivery orders issued to date totaling approximately $3.14 million. A $15.999 million single-award contract (October 2023–October 2028) covers retrieval, storage, inventory, distribution, and disposal of government-owned pharmaceutical materials including BioThrax and Ticovirimat. The Army Watercraft Sustainment Maintenance Program Zone 1 contract, awarded January 30, 2026, carries a $241.4 million ceiling and performance through July 30, 2031, providing comprehensive watercraft inspection, maintenance, and sustainment services; seven task orders under this vehicle total $10.5 million in combined potential value. An additional $34.6 million single-award IDC (September 2024–September 2029) provides assembly, manufacturing, storage, and distribution for Defense Biological Product Assurance Office products. The Naval Sea Systems Command Unmanned Surface Vehicle Family of Systems contract carries a $982.1 million ceiling through April 2029 for design, integration, combat systems, and payload development supporting unmanned maritime systems.

Recent concrete work includes a $2.75 million delivery order (February 2026–February 2029) under JE-CLASS II for retrieval, storage, inventory, distribution, and disposal of Anthrax Vaccine Absorbed; a $20.3 million cost-plus-fixed-fee delivery order (June 2023–February 2027, designated total small business set-aside) for performance-based logistics on Biological Integrated Detection Systems, Joint Biological Point Detection Systems, and Joint Portal Shield equipment across CONUS and overseas; a $4.58 million firm fixed-price delivery order (June 2025–October 2026, Army Forces Command) for unprogrammed repairs to Modular Warping Tug 03 under the Army Watercraft Sustainment Maintenance Zone 1 contract; and a $3.31 million delivery order (September 2024–September 2029) for assembly and manufacturing of end items incorporating government-provided lateral flow immunoassay strips. Murtech's category concentration spans Other Measuring and Controlling Device Manufacturing (28 awards), Refrigerated Warehousing and Storage (18 awards), and Ship Building and Repairing (10 awards), with PSC codes dominated by In Vitro Diagnostic Substances and Reagents (16 awards) and Chemical and Pharmaceutical Products Manufacturing Machinery (15 awards).

Activity has contracted markedly in the most recent two years—ten awards in 2023, declining to eight in 2024 and five in 2025—signaling either procurement consolidation or reduced volume from prime customers. Six awards carrying combined potential value of $30.3 million face ultimate completion within the next twenty-four months and will require recompete. The company operates almost exclusively as a prime, with only one identified sub-award and minimal SCI-reported service-contract activity (1.5 FTEs in FY2022 across sub-contract work), indicating the portfolio is dominated by goods, products, and fixed-price logistics services rather than time-and-materials professional services. Murtech has been a registered federal contractor since 2005.